SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Honasa Consumer gets nod to acquire Fluence Pharma

24 Jun 2026 Evaluate

Honasa Consumer has received approval for the acquisition of Fluence Pharma, which offers condition-specific OTC supplement under the brand ‘Hair Fact, Skin Fact and Pro Fact’. The company will acquire majority 58% equity stake of Fluence Pharma via secondary purchase at Rs 135 crore enterprise value, subject to closing adjustments and completion of conditions precedent. The company will acquire remaining 42% equity stake of Fluence Pharma via secondary purchase in two tranches over the next 5-7 years from completion of acquisition of aforesaid stake.

This strategic acquisition marks Honasa's entry into the high-growth nutraceuticals space, reinforcing its commitment to building science-backed solutions that address evolving consumer needs across ‘inside-out’ beauty. Through this acquisition, Honasa Consumer will execute its entry into the category by establishing its dedicated subsidiary, Honasa Health. Under this new entity, the company will scale a highly differentiated B2C nutrition portfolio by combining Fluence’s patented clinical science and deep practitioner trust with its own expertise in brand building, consumer insights, and digital-first distribution. The board of directors of the company at its meeting held on June 23, 2026 approved the same. 

Honasa Consumer, doing business as Mamaearth, provides e-commerce services. The company offers baby, skin, body, and hair care products, as well as mosquito protection roll on and creams.


Honasa Consumer Share Price

458.40 12.10 (2.71%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 276.10
Amrapali Industries 32.28
Adani Enterprises 3036.10
Rashi Peripheral 772.40
PDS 364.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: